logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Kensei Yamaguchi

Department of Gastroenterological Chemotherapy

65H指数
921论文数
2.2W被引数
收录论文 260
发表时间
logo
Dual-emission microparticle tracers for simultaneous thermometry and velocimetry in liquid thermal convection双发射微粒子示踪剂用于液体热对流中的同步温度和速度测量
errJournal of Luminescence
IF3.6
err2026-09-24
err0
PREAI
errKensei Yamaguchi; Keiko Ishii
err分享
err收藏
Precision therapeutic strategies for advanced gastrointestinal stromal tumors针对晚期胃肠道间质瘤的精准治疗策略
errCancer and Metastasis Reviews
IF8.7
err2026-09-19
err0
PREAI
errAkira Ooki; Hiroki Osumi; Keitaro Shimozaki; Shohei Udagawa; Kensei Yamaguchi
err分享
err收藏
Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study日本接受 fruquintinib 治疗的转移性结直肠癌患者中，蛋白尿作为早期剂量调整的原因：一项多中心真实世界研究
errInternational Journal of Clinical Oncology
IF2.8
err2026-08-27
err0
errOAAI
errShohei Udagawa; Chihiro Ishizuka; Hiroki Osumi; Toshiharu Hirose; Natsuko Okita; Hidekazu Hirano; Hirokazu Shoji; Ken Kato; Koichiro Yoshino; Keitaro Shimozaki; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Akira Ooki; Keisho Chin; Kensei Yamaguchi; Atsuo Takashima; Eiji Shinozaki
err分享
err收藏
Paradigm Shifts in Perioperative Management of Colorectal Cancer: Personalization Based on Tumor Biology, Primary Site, and Recurrence Risk, and the Evolving Role of Organ Preservation
errInternational Journal of Molecular Sciences
IF4.9
err2026-08-15
err0
errOAAI
errKaoru Yoshikawa; Akira Ooki; Eiji Shinozaki; Eiichiro Toyokawa; Keito Suzuki; Manabu Shiozawa; Shin Maeda; Kensei Yamaguchi; Hiroki Osumi
err分享
err收藏
High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer大剂量地塞米松和延长输注时间可预防转移性结直肠癌患者奥沙利铂相关超敏反应
errInternational Journal of Clinical Oncology
IF2.8
err2026-05-27
err0
errOAAI
errKoichiro Yoshino; Hiroki Osumi; Akira Ooki; Shohei Udagawa; Mikako Tamba; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Keisho Chin; Kensei Yamaguchi; Eiji Shinozaki
err分享
err收藏
Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trialsZolbetuximab联合化疗在日本Claudin 18.2阳性胃癌或胃食管结合部腺癌患者中的应用：SPOTLIGHT和GLOW III期试验的合并亚组分析
errGastric Cancer
IF5.1
err2026-05-07
err0
errOAAI
errKensei Yamaguchi; Hirokazu Shoji; Hisateru Yasui; Eiji Oki; Daisuke Sakai; Tetsuya Hamaguchi; Akihito Tsuji; Takashi Oshima; Masahiro Tsuda; Keiko Minashi; Jianning Yang; Abraham Guerrero; Yoko Ueno; Maria Matsangou; Georgia Gourgioti; Yuka Nakanishi; Satomi Furuki; Kana Kuwamoto; Shunsuke Yamada; Kohei Shitara
err分享
err收藏
Timing and Risk Factors for Hyperglycemia Associated With Anamorelin Administration阿那莫林给药相关高血糖的发病时间及危险因素
errAnticancer Research
IF1.7
err2026-05-01
err0
PREAI
errAmakawa, Yoshihiro; Kobayashi, Kazuo; Nonomiya, Yuma; Shimizu, Hisanori; Kawakami, Kazuyoshi; Yokokawa, Takashi; Sasahira, Naoki; Ozaka, Masato; Takeda, Tsuyoshi; Yamaguchi, Kensei; Takahari, Daisuke; Nishio, Makoto; Ariyasu, Ryo; Kitazawa, Toru; Yamaguchi, Masakazu
err分享
err收藏
Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer胃癌辅助CAPOX化疗患者中药房门诊随访对维持相对剂量强度的作用
errMolecular and Clinical Oncology
IF1.4
err2026-05-01
err0
PREAI
errNakamura, Masashi; Yokokawa, Takashi; Kawakami, Kazuyoshi; Kimura, Yuka; Shimizu, Hisanori; Kobayashi, Kazuo; Aoyama, Takeshi; Suzuki, Wataru; Hatori, Masahiro; Suzuki, Kenichi; Takahari, Daisuke; Ogura, Mariko; Chin, Keisho; Wakatsuki, Takeru; Yamaguchi, Kensei; Yamaguchi, Masakazu
err分享
err收藏
Role of tumor markers before or during chemotherapy for digestive neuroendocrine carcinomas as an exploratory analysis of JCOG1213消化神经内分泌癌化疗前或化疗期间肿瘤标志物的角色：JCOG1213的探索性分析
errScientific Reports
IF3.9
err2026-04-16
err0
errOAAI
errTomoyuki Satake; Chigusa Morizane; Nozomu Machida; Yoshitaka Honma; Takuji Okusaka; Narikazu Boku; Ken Kato; Gakuto Ogawa; Yusuke Sano; Hiroshi Imaoka; Satoshi Kobayashi; Takeshi Terashima; Masafumi Ikeda; Naohiro Okano; Kensei Yamaguchi; Takuji Sato; Nobumasa Mizuno; Yuko Kitagawa; Masanori Terashima; Makoto Ueno
err分享
err收藏
Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023HER2阳性晚期胃癌患者真实世界中的治疗选择增加和生存改善（2011年至2023年）
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-04-11
err0
PREAI
errKeitaro Shimozaki; Akira Ooki; Kaoru Yoshikawa; Koichiro Yoshino; Shohei Udagawa; Hiroki Osumi; Shota Fukuoka; Takeru Wakatsuki; Mariko Ogura; Daisuke Takahari; Eiji Shinozaki; Keisho Chin; Kensei Yamaguchi
err分享
err收藏
A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA转移性结直肠癌的新纪元：循环肿瘤DNA的作用与临床意义
errBiomolecules
IF4.8
err2026-04-07
err0
errOAAI
errEiichiro Toyokawa; Akira Ooki; Eiji Shinozaki; Kaoru Yoshikawa; Keito Suzuki; Manabu Shiozawa; Shin Maeda; Kensei Yamaguchi; Hiroki Osumi
err分享
err收藏
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancerHER2阳性胃癌患者中肿瘤内HER2异质性对曲妥珠单抗德鲁替康疗效的临床影响
errGastric Cancer
IF5.1
err2026-04-02
err0
errOAAI
errKoichiro Yoshino; Manabu Takamatsu; Akira Ooki; Keisho Chin; Daisuke Takahari; Hiroki Osumi; Mariko Ogura; Mikako Tamba; Koshiro Fukuda; Keitaro Shimozaki; Shohei Udagawa; Shota Fukuoka; Eiji Shinozaki; Kensei Yamaguchi; Takeru Wakatsuki
err分享
err收藏
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial一线zolbetuximab联合mFOLFOX6和nivolumab治疗不可切除的CLDN18.2阳性胃或胃食管结合部腺癌：一项Ⅱ期临床试验
errNature Medicine
IF50
err2026-03-16
err0
errOAAI
errKohei Shitara; Hirokazu Shoji; Nicola Fazio; Sara Lonardi; Keun-Wook Lee; Li-Yuan Bai; Kensei Yamaguchi; Jean-Philippe Metges; Gianluca Masi; Denis Smith; Tae-Yong Kim; Maria Matsangou; Archita Shrivastava; Miaomai Zhou; Jason Hill; Abraham Guerrero; Xuewei Wang; Aziz Zaanan; Samuel J. Klempner
err分享
err收藏
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer基于拷贝数分析的癌基因主导性可能提示ERBB2依赖性及曲妥珠单抗应答在HER2阳性胃癌中的情况
errTargeted Oncology
IF4
err2026-03-15
err0
errOAAI
errTakeru Wakatsuki; Noriko Yamamoto; Naoki Ishizuka; Shuichi Hironaka; Keiko Minashi; Shigenori Kadowaki; Hidekazu Hirano; Hirokazu Shoji; Toshifumi Yamaguchi; Keisho Chin; Mariko Ogura; Izuma Nakayama; Hiroki Osumi; Arisa Ueki; Shigehisa Kitano; Narikazu Boku; Kensei Yamaguchi; Daisuke Takahari
err分享
err收藏
Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary纳武利尤单抗联合化疗在亚洲晚期或复发性胃或胃食管结合部癌患者中的应用（ATTRACTION-4研究）：简明语言摘要
errFuture Oncology
IF2.6
err2026-03-01
err0
errOAAI
errLi-Tzong Chen; Yoon-Koo Kang; Min-Hee Ryu; Do-Youn Oh; Sang Cheul Oh; Sun Young Rha; Keun-Wook Lee; Takeshi Omori; Kohei Shitara; Shinichi Sakuramoto; Ik-Joo Chung; Kensei Yamaguchi; Ken Kato; Sun Jin Sym; Shigenori Kadowaki; Kunihiro Tsuji; Jen-Shi Chen; Li-Yuan Bai; Sung-Yong Oh; Yasuhiro Choda; Hisateru Yasui; Kentaro Takeuchi; Yoshinori Hirashima; Shunsuke Hagihara; Narikazu Boku
err分享
err收藏
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649纳武利尤单抗联合化疗作为晚期胃、胃食管结合部及食管腺癌的一线治疗方案：CheckMate 649研究的5年随访结果
errAnnals of Oncology
IF65.4
err2026-02-11
err0
PREAI
errY.Y. Janjigian; K. Shitara; J.A. Ajani; L. Shen; M. Garrido; C. Gallardo; L. Wyrwicz; K. Yamaguchi; J.M. Cleary; E. Elimova; R. Bruges; M. Karamouzis; T. Skoczylas; A. Bragagnoli; T. Liu; M. Tehfe; T. Zander; R. Kowalyszyn; R. Pazo-Cid; M. Schenker
err分享
err收藏
Comparative study of the short-term outcomes of gastric cancer surgery between Japanese Gastric cancer association-certified and non-certified institutions: a retrospective cohort analysis using a national database in Japan日本胃癌协会认证与非认证机构胃癌手术短期结局的对比研究：一项基于日本国家数据库的回顾性队列分析
errGastric Cancer
IF5.1
err2026-01-02
err0
errOAAI
errTomoyuki Matsunaga; Hideki Endo; Hiroyuki Yamamoto; Koshi Kumagai; Shingo Kanaji; Hisato Kawakami; Chika Kusano; Ryoji Kushima; Mitsuhiro Fujishiro; Kensei Yamaguchi; Takaki Yoshikawa; Yuichiro Doki; Yoshihiro Kakeji; Yoshiyuki Fujiwara
err分享
err收藏
Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experienceZolbetuximab联合化疗在Claudin 18亚型2阳性晚期胃癌中的安全性与有效性：真实世界经验的初步报告
errJournal of Cancer Research and Clinical Oncology
IF2.8
err2025-12-18
err0
errOAAI
errKeitaro Shimozaki; Akira Ooki; Shota Fukuoka; Hiroki Osumi; Kaoru Yoshikawa; Koichiro Yoshino; Shohei Udagawa; Takeru Wakatsuki; Eiji Shinozaki; Mariko Ogura; Keisho Chin; Kensei Yamaguchi
err分享
err收藏
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort糖皮质激素在粒细胞集落刺激因子相关大血管血管炎中很少需要：日本癌症中心队列
errRHEUMATOLOGY
IF4.4
err2025-12-01
err0
PREAI
errMorita, Yuka; Takeda, Koichi; Osumi, Hiroki; Aoyama, Yosuke; Fukuda, Naoki; Shimozaki, Keitaro; Udagawa, Shohei; Fukuoka, Shota; Ogura, Mariko; Wakatsuki, Takeru; Ooki, Akira; Chin, Keisho; Shinozaki, Eiji; Takano, Toshimi; Shiga, Taro; Yamaguchi, Kensei
err分享
err收藏
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC早期较高的血浆瑞戈菲布浓度预示日本结直肠癌患者无进展生存期缩短
errCTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
err2025-11-04
err0
errOAAI
errKobayashi, Kazuo; Wakatsuki, Takeru; Sugiyama, Erika; Shinozaki, Eiji.; Tajima, Masataka; Ogura, Mariko; Chin, Keisho; Ooki, Akira; Osumi, Hiroki; Fukuoka, Shota; Udagawa, Shohei; Shimozaki, Keitaro; Aoyama, Takeshi; Nakano, Yasuhiro; Kawakami, Kazuyoshi; Suzuki, Wataru; Yokokawa, Takashi; Sato, Hitoshi; Yamaguchi, Masakazu; Yamaguchi, Kensei
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Eric Van Cutsem
H 指数: 174 · 论文数: 1.8K
J
Jaffer A. Ajani
H 指数: 152 · 论文数: 1.7K
J
Josep Tabernero
H 指数: 146 · 论文数: 2.7K
S
Salvatore Siena
H 指数: 113 · 论文数: 1.2K
R
Robert J. Mayer
H 指数: 110 · 论文数: 632
查看更多